Pages that link to "Q42556086"
Jump to navigation
Jump to search
The following pages link to Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid (Q42556086):
Displaying 50 items.
- Comparative tolerability of the newer fluoroquinolone antibacterials (Q28146268) (← links)
- Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes (Q28243911) (← links)
- Rapidly progressive cholestasis: An unusual reaction to amoxicillin/clavulanic acid therapy in a child (Q28368375) (← links)
- HLA association of amoxicillin-clavulanate--induced hepatitis (Q28375211) (← links)
- Prolonged cholestasis with ductopenia after administration of amoxicillin/clavulanic acid (Q28375781) (← links)
- Optimising case detection within UK electronic health records: use of multiple linked databases for detecting liver injury (Q28595842) (← links)
- Ammonium glycyrrhizin counteracts liver injury caused by lipopolysaccharide/amoxicillin-clavulanate potassium (Q32174781) (← links)
- Is the standard dose of amoxicillin-clavulanic acid sufficient? (Q34030839) (← links)
- Drug-induced liver disease (Q34057571) (← links)
- Safety profile of the fluoroquinolones: focus on levofloxacin (Q34110521) (← links)
- Drug- and chemical-induced cholestasis (Q34210563) (← links)
- Hyperbilirubinemia during quinupristin-dalfopristin therapy in liver transplant recipients: correlation with available liver biopsy results (Q34278834) (← links)
- Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort study (Q34658795) (← links)
- Hepatic safety of antibiotics used in primary care (Q35037383) (← links)
- Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles (Q35085772) (← links)
- Co-amoxiclav jaundice: clinical and histological features and HLA class II association. (Q35361803) (← links)
- Use of the UK General Practice Research Database for pharmacoepidemiology (Q35802395) (← links)
- Acute and clinically relevant drug-induced liver injury: a population based case-control study. (Q35826210) (← links)
- A case of amoxicillin-induced hepatocellular liver injury with bile-duct damage (Q35833154) (← links)
- Causality assessment in drug-induced hepatotoxicity. (Q35842573) (← links)
- Idiosyncratic drug hepatotoxicity (Q36148442) (← links)
- Acute liver failure due to amoxicillin and amoxicillin/clavulanate (Q36269276) (← links)
- Drug-Induced Liver Injury: Pattern Recognition and Future Directions (Q36412863) (← links)
- Hepatobiliary Quiz (Answers)-16 (2015). (Q36492514) (← links)
- Searching for a needle in a haystack: use of ICD-9-CM codes in drug-induced liver injury (Q36896031) (← links)
- Idiosyncratic drug-induced liver injury: an overview (Q36984240) (← links)
- Amoxicillin-Clavulanate-Induced Liver Injury. (Q37095609) (← links)
- Hepatotoxicity of antibacterials: Pathomechanisms and clinical (Q37682656) (← links)
- Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages (Q37724173) (← links)
- Antibiotic induced liver injury: what about children? (Q38144140) (← links)
- Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review (Q38207944) (← links)
- Ascertainment of acute liver injury in two European primary care databases. (Q38234453) (← links)
- Risk factors for severe or fatal drug-induced liver injury from amoxicillin-clavulanic acid (Q38243926) (← links)
- Drug-induced liver injury: an overview over the most critical compounds (Q38331202) (← links)
- Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study (Q38599575) (← links)
- Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case-control studies using two primary care databases in Europe. (Q38920121) (← links)
- Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases. (Q39063027) (← links)
- Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios (Q39900404) (← links)
- Cholangiopathy after short-term administration of piperacillin and imipenem/cilastatin (Q40600978) (← links)
- Genetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis? (Q41389082) (← links)
- Amoxycillin Clavulanate: an Assessment after 15 Years of Clinical Application (Q41520020) (← links)
- Mycophenolate mofetil for drug-induced vanishing bile duct syndrome (Q41839389) (← links)
- An Uncommon Side Effect of a Commonly Used Antibiotic: Amoxicillin-Clavulanic Acid Induced Hepatitis (Q42260950) (← links)
- Cholestatic hepatitis due to amoxicillin-clavulanic acid with positive re-exposure (Q44479769) (← links)
- Amoxicillin induced acute hepatitis (Q44970602) (← links)
- Cholestasis in an elderly patient with pneumonia (Q46889939) (← links)
- Severe Drug-Induced Liver Injury as an Adverse Drug Event of Antibiotics: A Case Report and Review of the Literature (Q49960352) (← links)
- Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. (Q51635879) (← links)
- Idiosyncratic drug hepatotoxicity: a 2008 update. (Q51712894) (← links)
- Idiopathic acute liver injury in paediatric outpatients: incidence and signal detection in two European countries (Q51877937) (← links)